Company Filing History:
1 out of 235 
1 out of 5 Years Active: 2019
Title: Innovations of Tijia Chen in Tumor Targeting Polypeptides
Introduction
Tijia Chen is an accomplished inventor based in Sichuan, China. He has made significant contributions to the field of biotechnology, particularly in the development of polypeptides that target tumors. His innovative work has the potential to enhance cancer treatment by improving the delivery of therapeutic agents to tumor sites.
Latest Patents
Tijia Chen holds a patent for a novel nRGD polypeptide. This polypeptide is formed by connecting alanine-alanine-asparagine (AAN) with a polypeptide containing arginine-glycine-aspartic acid (RGD). The nRGD polypeptide is designed to target tumor vessels, tumor cells, and tumor-associated macrophages, facilitating the targeted delivery of therapeutic agents to tumors.
Career Highlights
Throughout his career, Tijia Chen has worked with notable institutions, including Sichuan University and Yaopharma Co., Ltd. His experience in these organizations has allowed him to collaborate with other experts in the field and contribute to groundbreaking research.
Collaborations
Tijia Chen has collaborated with esteemed colleagues such as Zhirong Zhang and Tao Gong. Their combined expertise has further advanced the research and development of innovative solutions in cancer treatment.
Conclusion
Tijia Chen's work in developing tumor-targeting polypeptides represents a significant advancement in cancer therapy. His innovative approach has the potential to improve treatment outcomes for patients battling cancer.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.